betnovate 1/2 betamethasone 0.5mg/g (as valerate) ointment tube
aspen pharmacare australia pty ltd - betamethasone valerate, quantity: 0.61 mg/g (equivalent: betamethasone, qty 0.5 mg/g) - ointment - excipient ingredients: liquid paraffin; white soft paraffin - indications as at 23 april 2004 : eczema including : atopic, infantile, stasis and discoid eczemas. besnier's (flexural) prurigo. otitis externa. neurodermatoses including lichen simplex, lichen planus. seborrheic dermatitis, contact sensitivity reactions and allergies.
betnovate betamethasone 1mg/g (as valerate) ointment tube
aspen pharmacare australia pty ltd - betamethasone valerate, quantity: 1.22 mg/g (equivalent: betamethasone, qty 1 mg/g) - ointment - excipient ingredients: liquid paraffin; white soft paraffin - indications as at 23 april 2004 : eczema including : atopic, infantile, stasis and discoid eczemas. besnier's (flexural) prurigo. otitis externa. neurodermatoses including lichen simplex, lichen planus. seborrheic dermatitis, contact sensitivity reactions and allergies.
betnovate ointment 0.1%w/w
al baker trading establishment united kingdom - 30 g tube - ointment - 0.1%w/w - skin-topical corticosteroids
betnovate ointment
30 g tube -
betnovate ointment 0.1% w/w
glaxosmithkline (ireland) limited - betamethasone valerate - ointment - 0.1 percent weight/weight - corticosteroids, potent (group iii); betamethasone
betnovate rd (ready diluted) 0.025% w/w ointment
glaxosmithkline (ireland) limited - betamethasone valerate - ointment - 0.025 percent weight/weight - corticosteroids, potent (group iii); betamethasone
betnovate ointment 0.1% w/w
glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - betamethasone valerate - ointment - betamethasone valerate 0.1 % (w/w) - corticosteroids, dermatological preparations
betnovate c
glaxosmithkline nz limited - betamethasone valerate 0.1%{relative} (0.122% with overage); clioquinol 3%{relative} - topical ointment - active: betamethasone valerate 0.1%{relative} (0.122% with overage) clioquinol 3%{relative} excipient: liquid paraffin white soft paraffin - betnovate-c preparations are indicated for the treatment of the following conditions where secondary bacterial and/or fungal infection is present, suspected or likely to occur:- eczema including atopic, and discoid eczemas. prurigo nodularis. psoriasis (excluding widespread plaque psoriasis). neurodermatoses including lichen simplex, lichen planus. seborrhoeic dermatitis. contact sensitivity reactions. insect bite reactions. prickly heat. anal and genital intertrigo. otitis externa.
betnovate 1/2 cream
aspen pharmacare australia pty ltd - betamethasone valerate, quantity: 0.61 mg/g (equivalent: betamethasone, qty 0.5 mg/g) - cream - excipient ingredients: cetomacrogol 1000; cetostearyl alcohol; white soft paraffin; liquid paraffin; purified water; chlorocresol; monobasic sodium phosphate; phosphoric acid; sodium hydroxide - indications as at 23 april 2004 : eczema including : atopic, infantile, stasis and discoid eczemas. besnier's (flexural) prurigo. otitis externa. neurodermatoses including lichen simplex, lichen planus. seborrheic dermatitis, contact sensitivity reactions and allergies.
betnovate ointment
glaxo wellcome uk limited - betamethasone valerate - ointment - betamethasone valerate 0.122 % (w/w) - corticosteroids, dermatological preparations